The global antiphospholipid syndrome score (GAPSS), constructed in combination with cardiovascular risk factors and aPL antibodies in the criteria, was found to be more effective at predicting the clinical findings associated with aPS when aPS/PT positivity was included in the assessment [11]. Here, FASLG is linked to antiphospholipid syndrome.